Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ended December ...

Inogen reported total revenue of $81.7 million for the fourth quarter of 2025, a 2% increase compared to the same period last year, primarily driven by higher growth in international ...

Delivered full year revenue growth of approximately 4%. Significantly improved profitability with 2025 net loss of $22.7 ...

Inogen Inc. (INGN) on Tuesday reported a loss of $7.1 million in its fourth quarter. The Beverly, Massachusetts-based company said it had a loss of 26 ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited ...

Noted a shift of large customer orders from Q4 2025 into the first half of 2026 due to customer capital and budgeting ...

Inogen Inc ( (INGN)) has released its Q3 earnings. Here is a breakdown of the information Inogen Inc presented to its investors. Inogen, Inc. is a global medical technology company specializing in ...

Welcome to Inogen's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, November 5, 2025. I'd now like to turn the call over to ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, ...